G. Kaiser

557 total citations
20 papers, 451 citations indexed

About

G. Kaiser is a scholar working on Analytical Chemistry, Pharmacology and Animal Science and Zoology. According to data from OpenAlex, G. Kaiser has authored 20 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Analytical Chemistry, 8 papers in Pharmacology and 4 papers in Animal Science and Zoology. Recurrent topics in G. Kaiser's work include Analytical Methods in Pharmaceuticals (9 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Pesticide Residue Analysis and Safety (4 papers). G. Kaiser is often cited by papers focused on Analytical Methods in Pharmaceuticals (9 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Pesticide Residue Analysis and Safety (4 papers). G. Kaiser collaborates with scholars based in Switzerland, United States and United Kingdom. G. Kaiser's co-authors include Roland Ackermann, A. Sioufi, W. Dieterle, J.P. Dubois, J. B. Lecaillon, Maria Palmisano, Giovanni Della Cioppa, Jonathan N. King, F. Pommier and Ian Holmes and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Chromatography A and American Heart Journal.

In The Last Decade

G. Kaiser

20 papers receiving 419 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
G. Kaiser Switzerland	14	135	104	86	79	78	20	451
Parviz Mojaverian United States	18	103 0.8×	139 1.3×	48 0.6×	99 1.3×	29 0.4×	41	886
PA Meredith United Kingdom	14	158 1.2×	315 3.0×	62 0.7×	72 0.9×	37 0.5×	33	646
RG Shanks United Kingdom	12	146 1.1×	243 2.3×	29 0.3×	68 0.9×	71 0.9×	39	592
Karen Fried United States	12	57 0.4×	115 1.1×	50 0.6×	31 0.4×	39 0.5×	15	513
Carl‐Gunnar Regårdh Sweden	16	164 1.2×	192 1.8×	73 0.8×	56 0.7×	51 0.7×	24	1.0k
DB Jack United Kingdom	15	145 1.1×	105 1.0×	40 0.5×	60 0.8×	17 0.2×	40	609
CR Kumana Hong Kong	11	58 0.4×	101 1.0×	35 0.4×	55 0.7×	46 0.6×	36	354
HL Elliott United Kingdom	17	197 1.5×	381 3.7×	42 0.5×	65 0.8×	45 0.6×	57	876
Chii‐Ming Lai United States	14	106 0.8×	147 1.4×	23 0.3×	31 0.4×	32 0.4×	36	660
James E. Axelson Canada	18	141 1.0×	143 1.4×	23 0.3×	49 0.6×	44 0.6×	65	911

Countries citing papers authored by G. Kaiser

Since Specialization

Citations

This map shows the geographic impact of G. Kaiser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Kaiser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Kaiser more than expected).

Fields of papers citing papers by G. Kaiser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Kaiser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Kaiser. The network helps show where G. Kaiser may publish in the future.

Co-authorship network of co-authors of G. Kaiser

This figure shows the co-authorship network connecting the top 25 collaborators of G. Kaiser. A scholar is included among the top collaborators of G. Kaiser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Kaiser. G. Kaiser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vaidya, Soniya, et al.. (2015). Lung Delivery of Indacaterol and Mometasone Furoate Following Inhalation of QMF149 in Healthy Volunteers. Clinical Pharmacology in Drug Development. 5(4). 285–295. 4 indexed citations

Pascoe, Steven, Christine Reynolds, Warren Pleskow, et al.. (2011). Safety, tolerability and pharmacokinetics of single escalating doses of indacaterol, a once-daily beta2-agonist bronchodilator, in subjects with COPD. International Journal of Clinical Pharmacology and Therapeutics. 49(2). 153–161. 10 indexed citations

Abdulla, Salim, Mbaraka Amuri, Abdunoor M. Kabanywanyi, et al.. (2010). Early clinical development of artemether-lumefantrine dispersible tablet: palatability of three flavours and bioavailability in healthy subjects. Malaria Journal. 9(1). 253–253. 21 indexed citations

Sáez‐Llorens, Xavier, Ram Yogev, Adriano Arguedas, et al.. (2009). Pharmacokinetics and Safety of Famciclovir in Children with Herpes Simplex or Varicella-Zoster Virus Infection. Antimicrobial Agents and Chemotherapy. 53(5). 1912–1920. 16 indexed citations

Lecaillon, J. B., et al.. (1999). Pharmacokinetics and tolerability of formoterol in healthy volunteers after a single high dose of Foradil dry powder Inhalation via aerolizer TM. European Journal of Clinical Pharmacology. 55(2). 131–138. 75 indexed citations

Maurer, Martina, et al.. (1997). Pharmacokinetics of the angiotensin-convertingenzym e inhibitor, benazepril, and its active metabolite, benazeprilat, in dog. Xenobiotica. 27(8). 819–829. 22 indexed citations

Kaiser, G., et al.. (1996). Determination by HPLC with Electrochemical Detection of Formoterol RR and SS Enantiomers in Urine. Journal of Liquid Chromatography & Related Technologies. 19(6). 993–1005. 15 indexed citations

King, Jonathan N., et al.. (1995). Pharmacokinetics of the active metabolite of benazepril, benazeprilat, and inhibition of plasma angiotensin-converting enzyme activity after single and repeated administrations to dogs. American Journal of Veterinary Research. 56(12). 1620–1628. 29 indexed citations

Kaiser, G., et al.. (1993). Pharmacokinetics and pharmacodynamics of benazepril hydrochloride in patients with major proteinuria. European Journal of Clinical Pharmacology. 44(5). 463–466. 4 indexed citations

10.

Kaiser, G., Roland Ackermann, W. Dieterle, I. W. Reimann, & P. R. Bieck. (1992). Pharmacokinetics of the antidepressant levoprotiline after intravenous and peroral administration in healthy volunteers. Biopharmaceutics & Drug Disposition. 13(2). 83–93. 2 indexed citations

11.

Waldmeier, Felix, G. Kaiser, Roland Ackermann, et al.. (1991). The disposition of [¹⁴C]-labelled benazepril HC1 in normal adult volunteers after single and repeated oral dose. Xenobiotica. 21(2). 251–261. 26 indexed citations

12.

Ackermann, Roland, et al.. (1991). Determination of the antidepressant levoprotiline and itsN-desmethyl metabolite in biological fluids by gas chromatography/mass spectrometry. Journal of Mass Spectrometry. 20(11). 709–716. 1 indexed citations

13.

Kaiser, G., Roland Ackermann, Hans-Peter Gschwind, et al.. (1990). The influence of hepatic cirrhosis on the pharmacokinetics of benazepril hydrochloride. Biopharmaceutics & Drug Disposition. 11(9). 753–764. 12 indexed citations

14.

Kaiser, G., Roland Ackermann, W. Dieterle, et al.. (1990). Pharmacokinetics and pharmacodynamics of the ace inhibitor benazepril hydrochloride in the elderly. European Journal of Clinical Pharmacology. 38(4). 379–385. 21 indexed citations

15.

Kaiser, G., Roland Ackermann, & A. Sioufi. (1989). Pharmacokinetics of a new angiotensin-converting enzyme inhibitor, benazepril hydrochloride, in special populations. American Heart Journal. 117(3). 746–751. 47 indexed citations

16.

Kaiser, G., et al.. (1989). Pharmacokinetics of the angiotensin converting enzyme inhibitor benazepril·HCl (CGS 14 824 A) in healthy volunteers after single and repeated administration. Biopharmaceutics & Drug Disposition. 10(4). 365–376. 32 indexed citations

17.

Sioufi, A., F. Pommier, G. Kaiser, & J.P. Dubois. (1988). Determination of benazepril, a new angiotensin-converting enzyme inhibitor, and its active metabolite, benazeprilat, in plasma and urine by capillary gas chromatography-mass-selective detection. Journal of Chromatography B Biomedical Sciences and Applications. 434(1). 239–246. 41 indexed citations

18.

Lepeleire, Inge De, Anne Van Hecken, René Verbesselt, et al.. (1988). Interaction between furosemide and the converting enzyme inhibitor benazepril in healthy volunteers. European Journal of Clinical Pharmacology. 34(5). 465–468. 16 indexed citations

19.

Sioufi, A., et al.. (1988). Determination of the S(+)- and R(−)-enantiomers of baclofen in plasma and urine by gas chromatography using a chiral fused-silica capillary column and an electron-capture detector. Journal of Chromatography A. 450(2). 221–232. 31 indexed citations

20.

Kaiser, G., et al.. (1987). Determination of a new angiotensin converting enzyme inhibitor and its active metabolite in plasma and urine by gas chromatography-mass spectrometry. Journal of Chromatography B Biomedical Sciences and Applications. 419. 123–133. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact